MedPath

Patient Education in Patients With Chronic Obstructive Pulmonary Disease (COPD) - Effect and Costs

Not Applicable
Completed
Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Registration Number
NCT00705302
Lead Sponsor
Norwegian University of Science and Technology
Brief Summary

The aim of this study is to determine the long term effect of a self-help group in a patient education program for patients with chronic obstructive pulmonary disease (COPD).

Detailed Description

Pulmonary rehabilitation is aimed to increase the level of health of patients with COPD by increasing their self care ability. A recent updated systematic review concluded that evidence strongly supports respiratory rehabilitation as part of the spectrum of management of patients with chronic obstructive pulmonary disease (COPD). Studies of pulmonary rehabilitation programs lasting up to 18 months show that effects are mainly maintained throughout the duration of the program. The long term effect, however, is mostly studied for programs of shorter durations. Some of the studies with shorter duration have found that the achieved benefit was lost or diminished during the follow up period, while others have found that the effect has been maintained up to 18 months. Our necessity in the rehabilitative field is to find strategies to maintain benefits during time.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
88
Inclusion Criteria
  • (FEV1) lower that 75% of predicted
  • the ability to participate in physical activity
  • not been hospitalized the last month.
Exclusion Criteria
  • contraindications for physical activity

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
St. George's Respiratory Questionnaire (SGRQ) - Total scoreBaseline, 3, 6 and 12 months
Secondary Outcome Measures
NameTimeMethod
Patient Activation Measure (PAM)Baseline, 3, 6 and 12 months
The Perceived Quality of Life ScaleBaseline, 3, 6 and 12 months
6 minute walk test (6MWT)Baseline, 3, 6 and 12 months
Modified Borg scale (MBS) pre, during and post 6MWTBaseline, 3, 6 and 12 months

Trial Locations

Locations (1)

Department of Public Health and General Practice, Norwegian University of Science and Technology

🇳🇴

Trondheim, Norway

Department of Public Health and General Practice, Norwegian University of Science and Technology
🇳🇴Trondheim, Norway

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.